Benzinga | Jul 6, 2021 07:57AM EDT

Aptinyx To Participate In Cowen Psychedelics & Novel Mechanisms In Neuropsychiatry Summit Jul. 13

Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of nervous system disorders, today announced that management will participate in a fireside chat at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit on Tuesday, July 13 at 3:40 p.m. ET. A live webcast of the event will be available to clients of Cowen.